Company Monitoring Page for Shire

latest headlines for company on cafepharma

Auven Therapeutics pits rival PhIII dry eye drug against Allergan, Shire
Fierce Biotech
Fri, 11/13/15 - 11:01 am
Tags:
Auven Therapeutics, dry eye disease, Seciera, Restasis, Allergan, Shire, Lifitegrast
$5.9 Billion Buyout: 1 Number Underpins Shire's Huge Dyax Bet
Motley Fool
Sat, 11/7/15 - 12:45 pm
Tags:
M&A, Dyax, Shire
Shire to Acquire Dyax for $5.9 Billion to Bolster Rare Disease Drug Business
TheStreet.com
Mon, 11/2/15 - 08:10 am
Tags:
Shire, Dyax, M&A
The top 10 biopharma pipeline disasters of 2015
Fierce Biotech
Fri, 10/30/15 - 09:55 am
Tags:
Eli Lilly, GSK, AstraZeneca, Shire, Celladon, Takeda, Merck, Roche, Verastem, evacetrapib, Breo Ellipta, brodalumab, selumetinib, SHP625, Mydicar, Alisertib, suggammadex, sembragiline, Defactinib
Why Baxalta Earnings Beat Makes Shire Deal Doubtful
Bidness, ETC
Fri, 10/30/15 - 09:50 am
Tags:
Baxalta, Shire, earnings, M&A
Shire says its once-rejected eye drug is back on track with a Phase III success
Fierce Biotech
Tue, 10/27/15 - 09:42 am
Tags:
Shire, Lifitegrast, dry eye disease
Shire Vows to Pursue Baxalta Deal as Profit Beats Estimates
Bloomberg
Fri, 10/23/15 - 09:21 am
Tags:
Shire, Baxalta, innovation, earnings
Shire Aims to Refile Blockbuster Eye Drug in First Quarter
Bloomberg
Mon, 10/19/15 - 09:59 am
Tags:
Shire, dry eye disease, Lifitegrast
FDA eye drug rebuff adds to Shire's woes in Baxalta pursuit
Yahoo/Reuters
Sat, 10/17/15 - 03:10 pm
Tags:
FDA, Lifitegrast, Shire, Baxalta, M&A
3 ADHD Treatment Makers to Watch
Motley Fool
Mon, 10/12/15 - 08:49 am
Tags:
ADHD, Shire, JNJ, Eli Lilly
3 Big Drugs Likely To Hit The Market Soon
Investors.com
Wed, 09/30/15 - 04:56 pm
Tags:
Merck, Keytruda, Shire, Lifitegrast, Gilead Sciences, Genvoya
Shire chalks up victory in Vyvanse patent battle
Fierce Pharma
Fri, 09/25/15 - 08:47 pm
Tags:
Shire, Vyvanse, patents, ADHD, generics
Shire's once-daily extended-release ADHD drug now approved in Europe
BioPharma Dive
Tue, 09/22/15 - 11:35 am
Tags:
Shire, ADHD, Intuniv, Europe
Baxalta executive says will not do defensive M&A
Yahoo/Reuters
Thu, 09/17/15 - 09:54 am
Tags:
Baxalta, M&A, Shire
Pharma Deal-Making: In The Pink Of Health
Seeking Alpha
Wed, 09/16/15 - 10:26 am
Tags:
M&A, Baxalta, GSK, JNJ, Eli Lilly, Novartis, Perrigo, Shire
Shire PLC, Baxalta Inc: Investors’ Reactions To Higher Bid Reports
Bidness, ETC
Tue, 09/15/15 - 11:37 am
Tags:
Shire, Baxalta, investors, M&A
Shire weighs options to sweeten all-stock offer for Baxalta
Marketwatch
Mon, 09/14/15 - 08:13 am
Tags:
Shire, Baxalta, M&A
Will Shire Sweeten Its Takeover Offer For Baxalta Inc?
Bidness, ETC
Thu, 09/3/15 - 07:58 am
Tags:
Shire, Baxalta, M&A
Shire and Sangamo break up their gene-editing partnership
Fierce Biotech
Wed, 09/2/15 - 12:39 pm
Tags:
Shire, Sangamo, gene editing
Baxalta may have a new M&A-based strategy for spurning Shire
BioPharma Dive
Tue, 09/1/15 - 06:45 pm
Tags:
Shire, Baxalta, M&A, Ariad Pharma

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.